Pharming launches Joenja (leniolisib) commercially in Japan
Pharming announces the commercial launch of Joenja (leniolisib) in Japan for adult and pediatric patients with APDS aged 4 and older.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Pharming announces the commercial launch of Joenja (leniolisib) in Japan for adult and pediatric patients with APDS aged 4 and older.